热门资讯> 正文
Catheter Precision获得高达8800万美元的战略融资
2026-03-11 20:42
- Catheter Precision (VTAK) said it has secured up to $88M in strategic institutional financing commitments to fund accelerated growth.
- The financing provides capital to fund the company’s medical device operations and support the expansion of its newly acquired Flyte aviation platform.
- Catheter Precision (VTAK) on Tuesday completed the acquisition of the remaining 80.02% equity interest in Fly Flyte from Creatd (CRTDD), resulting in 100% ownership of the AI-enabled regional aviation operator.
- VTAK shares fell -9.8% premarket.
More on Catheter Precision
- Creatd sells remaining stake in Fly Flyte to Catheter Precision for about $12 mln in cash and equity
- Financial information for Catheter Precision
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。